Historical record - last NADAC publication: 5/22/2019

Product Information

PRISTIQ ER 100 MG TABLET is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $12.8531 per EA under NDC 00008122250. Its NADAC has been published 301 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the desvenlafaxine succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PRISTIQ ER 100 MG TABLET

desvenlafaxine succinate
$12.8531per EA
High Outlier

Strength

100 mg/1

NDC

00008122250

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

5/22/2019

Active Ingredients

DESVENLAFAXINE SUCCINATE

Approval Type

New Drug (NDA)

FDA Application

NDA021992

On Market Since

5/1/2008

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for PRISTIQ ER 100 MG TABLET has been published 301 times since Nov 28, 2013, and over the history we have for it it has risen 122.3%. The table below summarizes its recorded NADAC range and movement.

Current price$12.8531 per EA
All-time high$12.8531 (Aug 28, 2019)
All-time low$5.7826 (Nov 28, 2013)
Median price$9.4145
Average price$9.6773
Largest weekly change+9.7% (Jan 8, 2014)
Weeks tracked301
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+122.3%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PRISTIQ ER 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PRISTIQ ER 100 MG TABLET, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $12.8531 per EA (NDC 00008122250), effective Aug 28, 2019.

How has the price of PRISTIQ ER 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for PRISTIQ ER 100 MG TABLET has risen 122.3%. It has been tracked across 301 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PRISTIQ ER 100 MG TABLET?

Since Nov 28, 2013, the NADAC for PRISTIQ ER 100 MG TABLET has ranged from a low of $5.7826 (Nov 28, 2013) to a high of $12.8531 (Aug 28, 2019), with a median of $9.4145 per EA.

Are there cheaper alternatives to PRISTIQ ER 100 MG TABLET?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as PRISTIQ ER 100 MG TABLET, but none are currently priced below it.

Who manufactures PRISTIQ ER 100 MG TABLET?

PRISTIQ ER 100 MG TABLET (NDC 00008122250) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.